|
PTGX | Protagonist Therapeutics, Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.13 |
| Leverage | 8.02% |
| Market Cap | $ 4.8B |
| PE | 107.62 |
| Dividend Yield | 0.00% |
| Profit | $ 44.6m |
| Margin | 21.47% |
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.